Navigation Links
Medtronic Inc. Cancels Cardiovascular and Orthopedic Contracts With Novation
Date:2/24/2011

IRVING, Texas, Feb. 24, 2011 /PRNewswire/ -- Novation, the leading health care supply contracting company, announced today that Medtronic Inc. has cancelled five contracts with Novation that cover cardiovascular and orthopedic products.  Novation is owned by VHA Inc. and the University HealthSystem Consortium (UHC), and VHA and UHC members represent $2 billion in annual purchases for Medtronic in these product categories. Novation has been in constant contact with Medtronic and has made every effort to maintain member value in these high cost categories. Medtronic stated in a letter to Novation that the company wanted to manage their business relationships with hospitals locally, rather than through a national GPO contract.

"This move will likely raise costs for member organizations by eliminating the price protection that members benefit from through Novation's national agreements," said Pete Allen, senior vice president of sourcing operations at Novation. "In addition, through our contracts members generate cooperative returns, and have more favorable terms and conditions. The contracts also protect members from pricing confidentiality clauses, eliminate freight fees, and mandate that new technology is added to contracts when the technologies are released."

In response to Medtronic's action, 16 of the leading U.S. not-for-profit hospitals and academic medical centers sent an open letter to the chairman and chief executive officer of Medtronic Inc., stating their 'extreme disappointment' with Medtronic during this time of unprecedented cost pressures. Hospitals in this country are facing more than $155 billion in reduced government reimbursement over the next ten years; placing an unprecedented burden on their existing fragile financial viability.  Dissolution of the Novation contracts will force health care organizations to develop individual agreements with Medtronic in order to obtain discounted pricing and new terms and conditions. 

"Members have told us that Medtronic's unilateral decision to cancel its agreements with Novation will likely increase their costs and impair the efficiency with which they conduct business," stated Allen.

Novation has heard from many members that some medical device manufacturers are insisting on strict pricing confidentiality clauses in their local contracts as a condition of the agreement.  These so-called "gag" clauses, which are not present in Novation agreements, prohibit hospitals from sharing pricing information with group purchasing organizations and other third parties that provide services designed to manage and control costs, such as benchmarking and auditing services.

It is unclear whether Medtronic will allow hospitals that desire to purchase Medtronic product through a local agreement the ability to share purchasing information with their GPOs or other advisors retained to help manage costs.

Allen continued, "If medical device manufacturers are successful in limiting hospitals' ability to understand and discuss pricing with outside parties, then they will be able to sell at price points that are not rational or relevant. That dynamic will keep prices artificially high and increase costs to the hospitals."

In response to the complexities associated with contracts for high cost medical devices, especially in light of the Medtronic actions, Novation has taken the initiative to significantly enhance the valuable contracting support services health care providers are receiving at no additional expense.  

Effective immediately and continuing through 2011, Novation will provide hands-on member support for the negotiation of all agreements for major cardiac and orthopedic devices, if members request this support.  This service may be provided either indirectly through education and benchmarking assistance, or directly as the designated agent for contract negotiation on the member's behalf.

About Novation

Founded in 1998, Novation is the leading health care supply contracting company for more than 25,000 members of VHA Inc. and the University HealthSystem Consortium (UHC), two national health care alliances, and 5,500 members of Provista, LLC, representing 28,000 sites. Novation provides alliance members contract and price management and spend management services. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 600 suppliers. VHA, UHC and Provista members used Novation contracts to purchase nearly $40 billion in 2010.


'/>"/>
SOURCE Novation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Medtronic, Stryker, and BrainLAB Covered in New Surgical Navigation Market Research Reports Released by Millennium Research Group
2. PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear, Nose, and Throat Market
3. Renhuang Cancels Third Quarter 2010 Conference Call
4. Essilor Cancels Four Million Shares
5. Reportlinker Adds Product Pipeline in Medical Equipment Market - Robust Pipeline Strengthening the In-Vitro Diagnostics and Cardiovascular Devices Market
6. MAQUET Cardiovascular Launches New VASOVIEW 6 PRO Endoscopic Vessel Harvesting System
7. CardioVascular BioTherapeutics Submits FDA Application for Fast Track Status for CVBT-141B, CVBTs Biological Treatment for Diabetes Patients
8. Pervasis to Present Interim Data from Phase 1/2 Clinical Study of Novel Cell Therapy Targeting Peripheral Artery Disease at International Conference on Cell Therapy for Cardiovascular Diseases
9. Reportlinker Adds Europe Cardiovascular Devices Market Outlook to 2016
10. Prescient Medical, Inc. Presenting at the 5th Annual Canaccord Genuity Cardiovascular Conference
11. Amarin to Present at Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Belgium , June 24, 2016 ... today announced the appointment of Dr. Edward ... as a Non-Executive Director, effective June 23, 2016.Dr. ... Compensation and Nominations and Governance Committees.  As a ... will provide independent expertise and strategic counsel to ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... MD (PRWEB) , ... June 24, 2016 , ... ... protocols for human induced pluripotent stem (iPS) cells and other difficult to transfect ... G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is a ...
Breaking Medicine News(10 mins):